Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Solifenacin/Tamsulosin (Vesomni®)

Brand: Vesomni®
Indication: Treatment of Storage Symptoms associated with Benign Prostatic Hyperplasia
Disease category: Genito-urinary system
Commissioning responsibility: CCG
PbR excluded: No


Vesomni® one tablet daily is recommended for the treatment of moderate to severe storage symptoms (urgency, increased micturition frequency) and voiding symptoms associated with benign prostatic hyperplasia in men who are not adequately responding to treatment with tamsulosin monotherapy.


LMMG recommendation: Green
Click here to find the definitions for the colour classifications

Reason for decision:  Suitable for initiation in primary care

Supporting documents:

LMMG New Medicine Recommendation - Vesomni (287.4 KiB)

*FOR FYLDE & WYRE CCG ONLY* - For use in men who were already taking tamsulosin with some response; however the response was not adequate.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG



Green (see note above)

Green (restricted - not first line)